KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Notes Payables (2020)

Historic Notes Payables for Ginkgo Bioworks Holdings (DNA) over the last 1 years, with Q4 2020 value amounting to $300000.0.

  • Ginkgo Bioworks Holdings' Notes Payables changed N/A to $300000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $300000.0, marking a year-over-year change of. This contributed to the annual value of $300000.0 for FY2020, which is N/A changed from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Notes Payables stood at $300000.0 for Q4 2020.
  • In the past 5 years, Ginkgo Bioworks Holdings' Notes Payables ranged from a high of $300000.0 in Q4 2020 and a low of $300000.0 during Q4 2020